インデックス付き
  • Jゲートを開く
  • Genamics JournalSeek
  • アカデミックキー
  • ジャーナル目次
  • グローバル インパクト ファクター (GIF)
  • 中国国家知識基盤 (CNKI)
  • ウルリッヒの定期刊行物ディレクトリ
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • Google スカラー
このページをシェアする
ジャーナルチラシ
Flyer image

概要

Nevirapine Co-crystals Activity on Humans

Jelabel Hak

Nevirapine (NV) is a non-nucleoside switch transcriptase inhibits or used in blend with other antiretroviral drugs for the treatment of Human Immunodeficiency Virus (HIV) contaminations. NV directly inhibits switch transcriptase movement consequently stifling DNA replication of the HIV infection and is known to forestall HIV transmission from mother to baby. A solitary portion of NV directed to the mother at the beginning of work and to the infant inside 72 hours of delivery almost divided the pace of HIV transmission. Since NV is given only once to the mother and child it is moderately modest and simple to administer [1-3]. NV is essentially insoluble in water with a fluid solvency of 0.1 mg/ml-1 (pH 7, Temp. 37°C). As per the Biopharmaceutical Classification Index, NV is a Class II sedate for example it has a high permeability and a low solvency . The low pace of disintegration of NV is assumed to be the rate-restricting advance for assimilation of the medication [4]. Co-gems, a translucent structure, containing at least two different components in an unmistakable stoichiometric proportion was researched to enhance the solvency, bioavailability and the disintegration pace of NV.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません